ALZpath Inc.’s Post

Join my colleague, Tom Hubbard, on April 11 as he hosts a discussion on #innovation in early screening and diagnosis of Alzheimer's disease and other related dementias. Registration link below! #alzheimers #alzheimersdisease #healthcareinnovation

« If you can’t measure it, you can’t improve it. » I’m leaving Copenhagen with this simple, though profound sentence Lord Kelvin once said and Gavin Giovannoni bring back during an inspiring talk at #ECTRIMS2024, on how objective measures should be integrated in MS clinical care management. If you can’t measure actual disability progression, how could you demonstrate new drug efficacy on smouldering Multiple Sclerosis? How could you intervene as a clinician to propose and promote a comprehensive care management? If you can’t measure the hidden part of the iceberg between yearly clinical visit, i.e., the disease fluctuation and its impact on quality of life of patients living with MS, how could you support care and lower the burden of the disease? If you can’t measure MS comorbidities, highly prevalent in neurological chronic disease, how could you concretely monitor and manage fatigue, depression, etc.? These numerous challenges and clinical unmet needs are envisioned and now proven to be at least in part overcome by patient reported outcomes and objective measures. We came at #ECTRIMS2024 with three posters supporting this field and promoting the use of #digitalbiomarkers and #digitalhealthtechnologies, providing Ad Scientiam’s vision of a comprehensive monitoring of MS selected domains. First by demonstrating that #MSCopilot is able to objectively measure key functional parameters that are sensitive to the different MS phenotypes in a first of its kind real life cohort. Second, by presenting a clinical study design, MS-BOOST, that aims at validating two interventional digital modules designed to better monitor and manage fatigue and fatiguability from the confort of patients’ home and thus reduce perceived burden and impact on patients’ daily life. Finally, by discussing the challenges and unmet needs of a major comorbidity in MS, depression. We proposed a framework through MSCopilot to leverage existing modules to objectively capture its severity, detect sooner and manage its symptoms. We are now leaving #ECTRIMS2024 with even more trust and confidence that #MSCopilot and its different programs are heading towards the right direction and that this journey is only the beginning of a great adventure that involves many different key stakeholders of the MS community.

📅 Join us at ECTRIMS Patient Community Day! 🧠 We’re thrilled to announce that during ECTRIMS Patient Community Day, EMSP - European Multiple Sclerosis Platform will be promoting the EBV-MS and BEHIND-MS projects. These initiatives are paving the way for new insights and potential breakthroughs in the treatment and prevention of Multiple Sclerosis (#MS). 🔬 What we’re showcasing: - EBV-MS Project: Investigating the role of Epstein-Barr virus (#EBV) in the onset and progression of MS, with the aim of exploring potential antiviral treatments. - BEHIND-MS Project: Focusing on mapping the interactions between EBV and the immune system in people with MS, including identifying key biomarkers. 📰 Visit Us: We’ll be distributing brochures with detailed information about both projects, providing people with MS the opportunity to learn how these initiatives could impact their treatment and care. We invite everyone in the MS community to stop by, engage with our experts, and explore how these projects could transform the future of MS research and treatment. The Patient Community Day is available online and onsite with free registration ➡ https://lnkd.in/eXfC9J8t #ECTRIMS2024 #EBVMS #BEHINDMS #MultipleSclerosis #MSResearch #PatientCommunity #Healthcare #EUHorizon #HaDEA #ECTRIMS2024

I’m excited to moderate this important panel at The National Dementias Conference 2024 (https://lnkd.in/eH9jWa5E) next month! Please join us as we discuss new ideas and insights to take action to improve the journey to diagnosis and management of Alzheimer's. And learn more about our research into a potential tau-targeting treatment for Alzheimer’s disease by visiting www.taurx.com. #Dementias24 #Alzheimers #DementiaExperts 

Join our upcoming webinar on Patient Centricity in Neurodegenerative Diseases on July 11th and learn how to integrate patient-centric approaches in clinical research. Neurodegenerative diseases have a profound impact on patients, caregivers, and healthcare systems. While advancements have been made, there's a critical need to amplify patient and caregiver voices throughout the research journey. This webinar brings together experts from pharma and patient advocacy groups to discuss: • Patient-centric precision medicine: • The crucial role of biomarkers in treatment development • Why patient & caregiver input matters in clinical trial design and execution Register now and ensure patients are at the forefront of research! https://lnkd.in/gXVzYwbK #CNS #NeurodegenerativeDisorders #PatientCentricity #DigitalBiomarkers #ImagingBiomarkers #ClinicalTrialEndpoints #COA #Parkinsons #Alzheimers #ClinicalTrials #PrecisionMedicine

Primary Care, Internal Medicine, Direct Primary care learn more about the use AI machine tools for your patients cognitive health. #cognitive #dementia #Alzheimer’s #brain #primarycare #AI #digitalhealth #diseasemonitoring

Had the great opportunity to speak with Altoida, Inc. CEO Marc Jones about their digital platform for early MCI/Alzheimer's screening. With an aging population and neurologist shortages, and new Alzheimer's drugs on the market, accurate and accessible diagnostics are crucial. Tools like Altoida’s could transform early detection and care as new Alzheimer’s treatments emerge. This is Part I: Overview on #Alzheimer's and #diagnostics to screen early for disease. #MCI #Alzheimers #dementia #diagnostics Citeline Citeline Commercial #medtech #screening

Join our upcoming webinar on Patient Centricity in Neurodegenerative Diseases on July 11th and learn how to integrate patient-centric approaches in clinical research. Neurodegenerative diseases have a profound impact on patients, caregivers, and healthcare systems. While advancements have been made, there's a critical need to amplify patient and caregiver voices throughout the research journey. This webinar brings together experts from pharma and patient advocacy groups to discuss: • Patient-centric precision medicine: • The crucial role of biomarkers in treatment development • Why patient & caregiver input matters in clinical trial design and execution Register now and ensure patients are at the forefront of research! https://lnkd.in/gudt2K6B #CNS #NeurodegenerativeDisorders #PatientCentricity #DigitalBiomarkers #ImagingBiomarkers #ClinicalTrialEndpoints #COA #Parkinsons #Alzheimers #ClinicalTrials #PrecisionMedicine

Join our upcoming webinar on Patient Centricity in Neurodegenerative Diseases on July 11th and learn how to integrate patient-centric approaches in clinical research. Neurodegenerative diseases have a profound impact on patients, caregivers, and healthcare systems. While advancements have been made, there's a critical need to amplify patient and caregiver voices throughout the research journey. This webinar brings together experts from pharma and patient advocacy groups to discuss: • Patient-centric precision medicine: • The crucial role of biomarkers in treatment development • Why patient & caregiver input matters in clinical trial design and execution Register now and ensure patients are at the forefront of research! https://lnkd.in/gurCseG3 #CNS #NeurodegenerativeDisorders #PatientCentricity #DigitalBiomarkers #ImagingBiomarkers #ClinicalTrialEndpoints #COA #Parkinsons #Alzheimers #ClinicalTrials #PrecisionMedicine

Join our upcoming webinar on Patient Centricity in Neurodegenerative Diseases on July 11th and learn how to integrate patient-centric approaches in clinical research. Neurodegenerative diseases have a profound impact on patients, caregivers, and healthcare systems. While advancements have been made, there's a critical need to amplify patient and caregiver voices throughout the research journey. This webinar brings together experts from pharma and patient advocacy groups to discuss: • Patient-centric precision medicine: • The crucial role of biomarkers in treatment development • Why patient & caregiver input matters in clinical trial design and execution Register now and ensure patients are at the forefront of research! https://lnkd.in/dh5C2AHb #CNS #NeurodegenerativeDisorders #PatientCentricity #DigitalBiomarkers #ImagingBiomarkers #ClinicalTrialEndpoints #COA #Parkinsons #Alzheimers #ClinicalTrials #PrecisionMedicine